New Delhi: Trial of the first indigenous vaccine covariant of the coronavirus began on Friday at the All India Institute of Medical Sciences (AIIMS), Delhi. The first dose of the coronavirus vaccine given to a 30-year-old man.
On the first day, five people who gave their consent to join the trial are being vaccinated. Professor of Community Medicine, who is leading the trial at AIIMS, Dr. Sanjay Roy said that screening of those who have registered for the trial is going on. Investigation report of many people has come. If everything is correct then the vaccination work will start.
It is being told that 3500 people have registered to join the trial. All these are being called for an investigation in AIIMS and samples are being taken for their investigation. Because this vaccine will be applied to healthy people. The sample is being sent to Gobar Lab for examination.
50 types of tests done including diabetes, hypertension, kidney, liver, heart diseases. Because of this, the investigation report is taking some time. The test will be conducted only on those who have passed the test. By the way, the investigation report of many people has come. Those who have good reports are being selected for the trial.
100 people to be tried
Bharat Biotech International Limited has developed this vaccine in collaboration with the Indian Council of Medical Research, New Delhi. Whose trial is going on in 12 institutions across the country.
The first phase at AIIMS is to be conducted at 100 people. After initially vaccinating 10 people, its report will be reviewed by the AIIMS Ethics Committee. Others will be vaccinated after reviewing vaccine safety.